Vascular Microenvironment, Tumor Immunity and Immunotherapy DOI Creative Commons
Zachary L Lamplugh, Yi Fan

Frontiers in Immunology, Journal Year: 2021, Volume and Issue: 12

Published: Dec. 20, 2021

Immunotherapy holds great promise for treating cancer. Nonetheless, T cell-based immunotherapy of solid tumors has remained challenging, largely due to the lack universal tumor-specific antigens and an immunosuppressive tumor microenvironment (TME) that inhibits lymphocyte infiltration activation. Aberrant vascularity characterizes malignant tumors, which fuels formation immune-hostile induces resistance immunotherapy, emerging as a crucial target adjuvant treatment in cancer immunotherapy. In this review, we discuss molecular cellular basis vascular microenvironment-mediated evasion immune responses with focus on vessel abnormality, dysfunctional adhesion, niche, microenvironmental stress vasculature. We provide overview opportunities challenges related these mechanisms. also propose genetic programming endothelial cells alternative approach recondition overcome

Language: Английский

All Roads Lead to the Liver: Metal Nanoparticles and Their Implications for Liver Health DOI
Adrian Boey, Han Kiat Ho

Small, Journal Year: 2020, Volume and Issue: 16(21)

Published: March 12, 2020

Abstract Metal nanoparticles (NPs) are frequently encountered in daily life, and concerns have been raised about their toxicity safety. Among which, they naturally accumulate the liver after introduction into body, independent of route administration. Some NPs exhibit intrinsic pharmaceutical effects that related to physical parameters, inadvertent accumulation can exert strong on function structure. Even as such physiological consequences often categorically dismissed toxic deleterious, there cell type‐specific NP‐specific biological responses elicit distinctive pharmacological be harnessed for good. By limiting scope discussion metallic NPs, this work attempts provide a balanced perspective safety liver, discusses both possible therapeutic benefits potential accidental damage arising from interaction with specific parenchymal nonparenchymal types liver.

Language: Английский

Citations

97

Endothelial-to-mesenchymal transition compromises vascular integrity to induce Myc-mediated metabolic reprogramming in kidney fibrosis DOI Open Access
Sara Lovisa,

Eliot Fletcher-Sananikone,

Hikaru Sugimoto

et al.

Science Signaling, Journal Year: 2020, Volume and Issue: 13(635)

Published: June 9, 2020

Endothelial-to-mesenchymal transition (EndMT) is a cellular transdifferentiation program in which endothelial cells partially lose their identity and acquire mesenchymal-like features. Renal capillary can undergo EndMT association with persistent damage of the renal parenchyma. The functional consequence(s) kidney fibrosis remains unexplored. Here, we studied effect Twist or Snail deficiency on fibrosis. Conditional deletion Twist1 (which encodes Twist) Snai1 Snail) VE-cadherin+ Tie1+ inhibited emergence improved two different injury/fibrosis mouse models. Suppression limited peritubular vascular leakage, reduced tissue hypoxia, preserved tubular epithelial health function. Hypoxia, was exacerbated by EndMT, resulted increased Myc abundance cells, enhanced glycolysis, suppression fatty acid oxidation. Pharmacological epithelial-specific genetic ablation ameliorated restored parenchymal function metabolic homeostasis. Together, these findings demonstrate role for response to injury highlight contribution endothelial-epithelial cross-talk development potential therapeutic intervention.

Language: Английский

Citations

89

Endothelial-to-Mesenchymal Transition (EndoMT): Roles in Tumorigenesis, Metastatic Extravasation and Therapy Resistance DOI Open Access

Valentin Platel,

Sébastien Faure, Isabelle Corre

et al.

Journal of Oncology, Journal Year: 2019, Volume and Issue: 2019, P. 1 - 13

Published: Aug. 1, 2019

Cancer cells evolve in a very complex tumor microenvironment, composed of several cell types, among which the endothelial are major actors angiogenesis. Today, these also characterized for their plasticity, as have demonstrated potential to modify phenotype differentiate into mesenchymal through endothelial-to-mesenchymal transition (EndoMT). This cellular plasticity is mediated by various stimuli including transforming growth factor- β (TGF- ) and modulated dependently experimental conditions. Recently, emerging evidences shown that EndoMT involved development dissemination cancer escape from therapeutic treatment. In this review, we summarize current updates on its main induction pathways. addition, discuss role tumorigenesis, metastasis, implication therapy resistance.

Language: Английский

Citations

83

Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1 DOI Creative Commons
Lina Song,

Guanglei Qiao,

Jian Yu

et al.

Journal of Experimental & Clinical Cancer Research, Journal Year: 2020, Volume and Issue: 39(1)

Published: June 17, 2020

Abstract Background Circular RNAs (circRNAs) play a critical regulatory role in cancer progression. However, the underlying mechanisms of circRNAs hepatocellular carcinoma (HCC) metastasis remain mostly unknown. Methods Has_circ_0003998 (circ0003998) was identified by sequencing HCC patients with /without portal vein tumor thrombus (PVTT) metastasis. The expression level circ0003998 further detected situ hybridization on tissues microarray (ISH-TMA) and qRT-PCR 25 PVTT Moreover, 50 without were recruited together to analyze correlation between clinical characteristics. Transwell, migration CCK8 assays, as well nude mice model lung or liver used evaluate epithelial mesenchymal transition (EMT) HCC. miR-143-3p PCBP1 determined dual-luciferase reporter assay, nuclear-cytoplasmic fractionation, fluorescent hybridization, RNA pull- down, microRNA sequence, western blot immunoprecipitation. Results Compared adjacent normal (ANL), significantly upregulated tissues, its correlates aggressive characteristics patients. Further assays suggested that promoted EMT both vitro vivo. Mechanistically, our data indicated may act ceRNA (competing endogenous RNA) microRNA-143-3p relieve repressive effect EMT-related stimulator, FOSL2; meanwhile, could bind PCBP1-poly(rC) binding protein 1 (PCBP1) increase genes, CD44v6. Conclusion Circ0003998 promotes circ0003998/miR-143-3p/FOSL2 axis /PCBP1/CD44v6 axis.

Language: Английский

Citations

74

Vascular Microenvironment, Tumor Immunity and Immunotherapy DOI Creative Commons
Zachary L Lamplugh, Yi Fan

Frontiers in Immunology, Journal Year: 2021, Volume and Issue: 12

Published: Dec. 20, 2021

Immunotherapy holds great promise for treating cancer. Nonetheless, T cell-based immunotherapy of solid tumors has remained challenging, largely due to the lack universal tumor-specific antigens and an immunosuppressive tumor microenvironment (TME) that inhibits lymphocyte infiltration activation. Aberrant vascularity characterizes malignant tumors, which fuels formation immune-hostile induces resistance immunotherapy, emerging as a crucial target adjuvant treatment in cancer immunotherapy. In this review, we discuss molecular cellular basis vascular microenvironment-mediated evasion immune responses with focus on vessel abnormality, dysfunctional adhesion, niche, microenvironmental stress vasculature. We provide overview opportunities challenges related these mechanisms. also propose genetic programming endothelial cells alternative approach recondition overcome

Language: Английский

Citations

73